Investing for Results
The Alzheimer’s Association is the largest private non-profit funder of Alzheimer’s research worldwide. Since 1982, the Alzheimer’s Association has invested over $435 million in more than 2,900 scientific investigations. Currently, the Association is investing over $110 million in nearly 400 best-of-field active projects in 18 countries. For more information on our International Research Grants Program, please visit our grants website.
Alzheimer’s Association Grants to MA/NH Researchers
2018 Local Grant Recipients – MA/NH Chapter
Ladan Amin, Ph.D.
Boston University
Alzheimer’s Association Research Fellowship Program
A new approach to visualize the interaction between Aß and its receptors
Simon Dujardin, Ph.D.
Massachusetts General Hospital
Alzheimer’s Association Research Fellowship Program
Understanding the molecular signature of Tau seeds in the human brain
Rodrigo Lopez Gonzalez, Ph.D.
Alzheimer’s Association Research Fellowship to Promote Diversity
University of Massachusetts Medical School
Emer McGrath, MD
Brigham and Women’s Hospital
2018 Alzheimer’s Association Clinical Scientist Fellowship}
Serum Biomarkers for Predicting Cognitive Decline and Dementia
Derek Oakley, Ph.D., M.D.
Massachusetts General Hospital
Alzheimer’s Association Clinician Scientist Fellowship
Tau aggregation and toxicity in patient derived iPS-neuro
Yakeel Quiroz, Ph.D.
Massachusetts General Hospital
Alzheimer’s Association Research Grant to Promote Diversity
Taking it to the extreme: The search for modifiers of cognitive decline
Amar Sahay, Ph.D.
Massachusetts General Hospital
Alzheimer’s Association Research Grant New to the Field
Targeting feed-forward inhibition in DG-CA3 to improve memory in AD
Nicole Spartano, Ph.D.
Boston Medical Center
Alzheimer’s Association Research Grant
Physical Inactivity, Epigenetic Aging, and Preclinical Dementia
Sarinnapha M. Vasunilashorn, PhD
Beth Israel Deaconess Medical Center
2018 Alzheimer’s Association Research Fellowship
Genetic and Inflammatory Mechanisms of Delirium and Alzheimer’s Disease
Dominic Walsh, PhD
2018 Zenith Fellows Award
A Blood-Based Molecular Fingerprint for Early Alzheimer’s Disease
Pain has an impact on behavior, function and quality of life for people living with dementia, but is one of the most mismanaged conditions. The challenges of understanding and treating acute and chronic pain for those with dementia are complex and often overlooked. Identifying and treating pain requires the ability to listen to what individuals are communicating through behaviors and body language. To treat pain for someone with dementia we must look beyond the words. This keynote offers the opportunity to explore strategies for identifying and managing pain including the use of standardized tools for assessment and monitoring along with the use of medications for individualizing comfort measures.
Melanie Bunn, GNP, MS, RN, is a Consulting Associate at the Duke University School of Nursing, Certified Trainer, Coach and Consultant for Teepa Snow’s Positive Approach to Care, and has her own education consulting company, Bunn Consulting. She received her degree in Nursing from the University of North Carolina-Chapel Hill, Master’s degree in Family Health Nursing from Clemson University and a Post-Master’s Gerontological Nurse Practitioner Certificate from Duke University. She has provided primary care to older people in a variety of settings including retirement homes, long term care nursing, assisted living facilities, hospitals, and in the home as a gerontological nurse practitioner, clinical nurse specialist and staff nurse. In 2014, Ms. Bunn was awarded the Dr. Ewald W. Busse Award by the NC Division of Aging and Adult Services Department of Health and Human Services for her contributions to improving the care of older adults with dementia and their families.
James Wessler
Paul S. Stuka
Barry Greene
Thomas A. Croswell